by Proxiva Peptides | Mar 7, 2026 | Fat Loss, Peptide Research
Introduction: Gut Healing vs GLP-1 Weight Loss — Two Peptides, Two Paradigms BPC-157 and semaglutide represent two of the most impactful peptides in modern research, but they target completely different physiological systems with fundamentally different mechanisms and...
by Proxiva Peptides | Mar 7, 2026 | Peptide Research, Tissue Repair
Introduction: Two Tissue-Remodeling Peptides With Different Targets GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) and BPC-157 (body protection compound-157) are two of the most researched tissue-remodeling peptides in modern pharmacology, yet they operate through...
by Proxiva Peptides | Mar 7, 2026 | Peptide Research, Sexual Health
Introduction: The Melanocortin Connection Melanotan II and PT-141 (bremelanotide) share a direct lineage in melanocortin peptide pharmacology. PT-141 is a metabolite of Melanotan II, making this comparison unique — one compound is literally derived from the other. Yet...
by Proxiva Peptides | Mar 7, 2026 | Nootropics, Peptide Research
Introduction: Russia’s Two Flagship Nootropic Peptides Semax and Selank are two synthetic peptides developed at the Institute of Molecular Genetics of the Russian Academy of Sciences, both achieving regulatory approval in Russia and several CIS countries for...
by Proxiva Peptides | Mar 7, 2026 | Fat Loss, Peptide Research
Introduction: The Fat Loss Research Landscape Fat loss research has exploded in recent years, driven by the global obesity epidemic and the unprecedented clinical success of GLP-1 receptor agonists like semaglutide. Within the research compound landscape, two classes...
by Proxiva Peptides | Mar 7, 2026 | Muscle Growth, Peptide Research
Introduction: Two Distinct Classes of Research Compounds The comparison between peptides and selective androgen receptor modulators (SARMs) represents one of the most fundamental questions in modern research compound pharmacology. Both classes have generated enormous...
